New York, Nov. 21, 2025 – Convergent Dental, the company behind the Solea® All-Tissue Dental Laser, announced its participation in the 37th Annual Piper Sandler Healthcare Conference, taking place December 2-4, 2025, in New York City.
The invitation-only event will feature over 400 leading companies across biotechnology, medical technology, pharmaceuticals, diagnostics, and healthcare services.
Robert L. Gershon, CEO of Convergent Dental, is scheduled to present on Tuesday, December 2, at 2:10 p.m. EST. In addition to his presentation, Convergent Dental will hold one-on-one meetings with investors and industry professionals to highlight the latest advancements in laser dentistry and the company’s strategy to drive broader adoption of Solea®.
Convergent Dental, Inc., a privately held dental equipment and technology company, markets Solea®, the only FDA-cleared CO2 laser for all-tissue dental procedures.
Solea® offers dentists and patients an anesthesia-free, blood-free, and suture-free experience, while enhancing efficiency, clinical outcomes, and procedural versatility.
According to internal documentation, 1,000 procedures performed by Solea® users demonstrate its clinical effectiveness. A 2022 annual survey of Solea® users further underscores its impact on patient experience and practice productivity.
